Indonesia vs Mali: Treatment coverage for schistosomiasis
Indonesia
40.5%
in 2024
Mali
39.3%
in 2024
Indonesia rank
27th
Mali rank
30th
Treatment coverage for schistosomiasis over time
- Indonesia
- Mali
How they compare
Indonesia currently reports 40.5% against 39.3% in Mali, a difference of 1.2%.
The two have swapped places 4 times across 12 shared years of data; in 2011 it was Indonesia ahead.
Indonesia ranks 27th and Mali ranks 30th of 45 countries.
Mali has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 50.1% | 53.1% | 3.1% | Mali |
| 2020s | 20.3% | 44.1% | 23.8% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Indonesia or Mali?
- Indonesia, at 40.5% against 39.3% in Mali as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Indonesia and Mali?
- 1.2%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Mali?
- 12 years are reported by both, from 2011 to 2024.
- How do Indonesia and Mali rank globally for treatment coverage for schistosomiasis?
- Indonesia ranks 27th and Mali ranks 30th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.